Matrine has been found in studies to drastically suppress the expression of HIF-1α and its downstream regulatory targets of glucose metabolism GLUT1, HK2 and LDHA in colon cancer HCT116 and SW620 cells, reversing the Warburg Effect (Hong et al., 2019). Here, SLC2A1 is linked to malignant colon neoplasm.